Initiation of preparation of CTD to use stem cells of the limbus has been observed with the cooperation of the stem cells sciences and technologies development headquarter as a step toward the commercialization of stem cells in ophthalmology.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, a meeting was held in the presence of Amir Ali Hamidieh, secretary of stem cells sciences and technologies development headquarter, eye doctors, and faculty members of universities and Royan research center.

This meeting was held to evaluate the situation of files of therapeutic use of limbus stem cells in food and drug organization. Patients suffering from defects in limbus stem cells due to chemical damages can soon benefit from this treatment.

One of the treatments of this disease is implant of limbus stem cells, for which prior clinical trials have been successfully performed by the team of Shahid Behesti University of Medical Sciences and researchers of Royan research center. Today, we are able to extend the use of this method in the country. Therefore, it was decided in this meeting that CTD be prepared by the members of the committee with the cooperation of stem cells sciences and technologies development headquarter to present to the food and drug organization.